# Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A

> **NCT06328712** · PHASE1 · COMPLETED · sponsor: **ENCell** · enrollment: 6 (actual)

## Conditions studied

- Charcot-Marie-Tooth Disease Type 1A

## Interventions

- **DRUG:** EN001

## Key facts

- **NCT ID:** NCT06328712
- **Lead sponsor:** ENCell
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-30
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06328712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06328712, "Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06328712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*